51. The Matrine Derivate MASM Prolongs Survival, Attenuates Inflammation, and Reduces Organ Injury in Murine Established Lethal Sepsis.
- Author
-
Xu J, Wang KQ, Xu WH, Li YH, Qi Y, Wu HY, Li JZ, He ZG, Hu HG, Wang Y, and Zhang JP
- Subjects
- Animals, Disease Models, Animal, Lipopolysaccharides toxicity, Male, Mice, Mice, Inbred C57BL, RAW 264.7 Cells drug effects, RAW 264.7 Cells immunology, Survival Analysis, Matrines, Alkaloids administration & dosage, Immunologic Factors administration & dosage, Inflammation drug therapy, Inflammation pathology, Quinolizines administration & dosage, Sepsis drug therapy, Sepsis pathology
- Abstract
Background: MASM, a novel derivative of matrine, has inhibitory effects on activation of macrophages, dendritic cells, and hepatic stellate cells and binds to ribosomal protein S5 (RPS5). This study was designed to evaluate the effect of MASM on murine-established lethal sepsis and its mechanisms., Methods: Mouse peritoneal macrophages and RAW264.7 cells that were infected with recombinant lentiviruses encoding shRPS5 were incubated with lipopolysaccharide (LPS) in the absence or presence of MASM in vitro. Endotoxemia induced by LPS injection and sepsis induced by cecal ligation and puncture was followed by MASM treatment., Results: MASM markedly attenuated LPS-induced release and messenger RNA expression of tumor necrosis factor α, interleukin 6, and NO/inducible NO synthase in murine peritoneal macrophages and RAW264.7 cells. Meanwhile, MASM inhibited LPS-induced activation of nuclear factor κB and MAPK pathways. Consistently, RPS5 suppressed LPS-induced inflammatory responses and at least in part mediated the antiinflammatory effect of MASM in vitro. Remarkably, delayed administration of MASM could significantly reduce mortality in mouse sepsis models, which was associated with the reduction in the inflammatory response, the attenuation in multiple organ injury, and the enhanced bacterial clearance., Conclusions: MASM could be further explored for the treatments of sepsis, especially for administration later after the onset of sepsis., (© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.)
- Published
- 2016
- Full Text
- View/download PDF